Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon

MEHMET ERHAN YUMUŞAK, (Kırıkkale Üniversitesi, Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Kırıkkale, Türkiye)
Fatih Mehmet MUTLU, (Kırıkkale Üniversitesi, Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Kırıkkale, Türkiye)
Ümit SARICA, (Kırıkkale Üniversitesi, Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Kırıkkale, Türkiye)
Reyhan OĞUREL (Kırıkkale Üniversitesi, Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Kırıkkale, Türkiye)
Retina-Vitreus
0 0
Yıl: 2015 Cilt: 23 Sayı: 2 Sayfa Aralığı: 179 - 185 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon

Öz:
Prematüre retinopatisi (PR), ilk tanımlanmasından sonra uzmanların üzerinde en çok tartıştıkları, tedavi seçeneklerinin gelişmesine rağmen özellikle tarama kriterleri ve tedavi endikasyonunun belirlemesinde muayene bulgularının standardizasyonu konusunda tam mutabakat sağlanamamıştır. Prematüre bebeklerin gözlerinin muayene zorlukları ve medikolegal sorunlar, tanı ve tedavinin standardizasyonun önüne geçmiştir. Plus hastalığı, hastalığın tanı ve tedavisinde önemli bir gösterge olarak kullanılmıştır. Son yıllarda sınıflamada yapılan revizyonlarla "eşik-PR", "eşik öncesi PR" ve "plus öncesi", gibi kavramlar gündeme gelmiş ve arka kutuptaki değişiklikler önem kazanmıştır. PR ile uğraşan hekimlerin plus hastalığının tanısına ve bu tanıda fikir birliğine yönelik olarak teknolojiyi kullanma istekleri son on yılda belirgin biçimde artmıştır. Bu derlemede PR ve plus hastalığının tanı ve tedaviyi yönlendirmedeki önemi ve bu konuda standardizasyonu sağlamak için yapılan yapılan çalışmalarla ilgili bilgi verilmesi amaçlanmıştır
Anahtar Kelime:

Konular: Göz Hastalıkları

Retinopathy of Prematurity, Diagnosis and Standardization of the Evaluation

Öz:
Retinopathy of prematurity (ROP) has been one of the issues about which the specialists have most argued but not compromised to that extent since its first definition. Restricted examination area of the eyes of the premature babies and difficulty of performing examination, and difficulty in achieving sufficient pupil dilatation have precluded the standardization of diagnosis and treatment. Plus disease, defined in 1980 has been used as an important indicator in the diagnosis and treatment of ROP. With a later revision, concepts such as preplus or threshold have been defined, and changes in posterior pole have gained much more importance. Desire of the ROP specialists in using technology towards the diagnosis of plus disease and consensus about the diagnosis has significantly increased in the last 10 years. In this article it was aimed to review the up-to-date studies about the diagnosis and treatment of ROP and plus disease
Anahtar Kelime:

Konular: Göz Hastalıkları
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
  • Patz A. Oxygen studies in retrolental fibroplasias: IV: Clinical and ex- perimental observations. Am J Ophthalmol 1954;38:291-308.
  • Ashton N. Oxygen and the retinal blood vessels. Trans OphthalmolSoc UK 1980;100:359-62.
  • No authors listed. An international classification of retinopathy of pre- maturity. ArchOphthalmol 1984;102:1130-4. 4. Davitt BV, Wallace DK. Plus disease. Surv Ophthalmol 2009;54:663-70.
  • Kretzer FL, Hittner HM. Retinopathy of prematurity: Clinical implica- tions of retinal development. ArchDis Child 1988;63:1151-67.
  • Smith LE. Pathogenesis of retinopathy of prematurity. GrowthHorm IGF Res 2004;14:S140-4.
  • Smith LE. Pathogenesis of retinopathy of prematurity. Semin Neona- tol 2003;8:469-73. 8. Dorrell MI, Aguilar E, Friedlander M. Retinal vascular development is mediated by endothelial filopodia, a preexisting strocytic templateand specific R-cadherin adhesion. Invest Ophthalmol Vis Sci.2002;43:3500-10.
  • Weidemann A, Krohne TU, Aguilar E, et al. Astrocyte hypoxic respon- se is essential for pathological but not developmental angiogenesis of the retina. Glia 2010;58:1177-85.
  • McColm JR, Geisen P, Hartnett ME. VEGF isoform sand the irexpression after a single episode of hypoxia or repeated fluctuations between hypero- xia and hypoxia: relevance to clinical ROP Mol Vis. 2004;21:512-20.
  • Chan-Ling T, McLeod DS, Hughes S, et al. Astrocyte-endothelial cell relationships during human retinal vascular development. Invest Oph- thalmol Vis Sci 2004;45:2020-32.
  • Smith LE, Kopchick JJ, Chen W, et al. Essential role of growth hormone in ischemia-induced retinal neovascularization. Scien- ce.1997;276:1706-9.
  • Seghezzi G, Patel S, Ren CJ, et al. Fibroblast growthfactor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism cont- ributing to angiogenesis. J Cell Biol 1998;141:1659-73.
  • Wilkinson-Berka JL, Babic S, De Gooyer T, et al. Inhibition of plate- let-derived growth factor promote spericyte loss and angiogenesis in ischemic retinopathy. Am J Pathol 2004;164:1263-73.
  • Gille J, Khalik M, König V, et al. Hepatocyte growth factor/ scatter fac- tor (HGF/SF) induces vascular permeability factor (VPF/VEGF) exp- ression by cultured keratinocytes. J Invest Dermatol 1998;111:1160-5.
  • Senger DR, Galli SJ, Dvorak AM, et al. Tumor cells secrete a vascular permeability factor that promote saccumulation of ascites fluid. Scien- ce 1983;219:983-5.
  • Smith LE. IGF-1 and retinopathy of prematurity in the preterm infant. Biol Neonate. 2005;88:237-44.
  • Chen J, Stahl A, Hellstrom A, et al. Current update on retinopathy of prematurity: screening and treatment. Curr Opin Pediatr 2011;23:173-8.
  • Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 2007;10:133-4.
  • Fielder AR, Posner EJ. Neonatal ophthalmology. In: Rennie JM, edi- tor. Robertons' Textbook of Neonatology. London: Elsevier Churchill Livingstone; 2005:835-50.
  • Sarici, SU; Mutlu, FM, Altinsoy HI. Retinopathy of prematurity. Jour- nal of Turkish National Pediatric Society 200851:51-61.
  • Saldır M, Sarici SU, Mutlu FM, et al. An analysis of neonatal risk factors associated with the development of ophthalmologic problems at infancy and early childhood: a study of premature infants born at or before 32 weeks of gestation. J Pediatr Ophthalmol Strabismus. 2010;47:331-7.
  • Saunders RA, Hutchinson AK. The future of screening for retinopathy of prematurity. J AAPOS. 2002;6:61-3.
  • Perez-Munuzuri A, Fernandez-Lorenzo JR, Couce-Pico ML, et al. Se- rum levels of IGF1 are a useful predictor of retinopathy of prematurity. Acta Paediatr 2010;99:519-25.
  • Löfqvist C, Andersson E, Sigurdsson J, et al. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity. Arch Ophthalmol 2006;124:1711-8.
  • Bizzarro MJ, Hussain N, Jonsson B, et al. Genetic susceptibility to retinopathy of prematurity. Pediatrics 2006;118:1858-63.
  • Cooke WI, Drury JA, Mountford R, et al. Genetic polymorphisms and retinopathy of prematurity. Invest Ophthalmol Vis Sci 2004;45:1712-5.
  • Vannay A, Dunai G, Banyasz I, et al. Association of genetic polymorp- hisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr Res 2005;57:396-8.
  • Prematüre Retinopatisi (TextBook of Retinopathy of Prematurity Aut- hors: Dr. Rajvardhan Azad, Dr. Michael T. Trese) Çeviri editörü: Le- vent TÖK, Hiperlink yayınları İstanbul, 2013.
  • Multicentre trial for cryotherapy for retinopathy of prematurity: preli- minary results. ArchOphthalmol 1988;106:471-9.
  • An International Committee for the classification of retinopathy of pre- maturity. The international classification of retinopathy of prematu- rity revisited. Arch Ophthalmol 2005; undefined. pp:991-9.
  • Hartnett ME, Martiniuk D, Byfield G, et al. Neutralizing VEGF decre- ases tortuosity and alters endothelial cell division orientation in arteri- oles and veins in a rat model of ROP: Relevance to plus disease. Invest Ophthalmol Vis Sci 2008;49:3107-14.
  • William V.G. Early treatment of retinopathy of prematurity co- operative group. Final results of the Early Treatment of Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004; undefined: pp. 233-248005;123:991-9.
  • Castro JR, Urcelay I, Mussons F, et al. Retinopathy of prematurity. Prevention, screening and treatment guidelines. Ann Pediatr (Barc) 2009;71:514-23.
  • Kemper AR, Wallace DK, Quinn GE. Systematic review of digital ima- ging screening strategies fo rretinopathy of prematurity. Pediatrics 2008;122:825-30.
  • Erol MK, Ozdemir O, Turgut Coban D, et al. Macular findings obtained by spectral domain optical coherence tomography in retinopathy of pre- maturity. J Ophthalmol 2014;2014:468-653.
  • Early treatment for retinopathy of prematurity cooperative group. Re- vised indications for the treatment of retinopathy of prematurity: Re- sults of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684-94.
  • Mutlu FM, Sarici SU. Treatment of retinopathy of prematurity: a re- view of conventional and promising new therapeutic options. Int J Ophthalmol 2013;6:228-36.
  • Gelman R, Martinez-Perez ME, Vanderveen DK, et al. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multi Scale Analysis. InvestOphthalmolVisSci 2005;46:4734-8.
  • Solarte CE, Awad AH, Wilson CM. Plus disease in retinopathy of prematurity .MEAJO 2010;17-2:148-55.
  • Wilson CM, Cocker KD, Moseley MJ, et al. Computerized analysis of retinal vessel width and tortuosity in premature infants. Invest Oph- thalmol Vis Sci 2008;49:3577-85.
  • Wilson, Clare Clinical and automated detection of the retinal vessels of premature infants with and without retinopathy of prematurity. PhD thesis 2009.
  • Martinez-Perez ME, Hughes AD, Stanton AV, et al. Retinal vascular tree morphology: A semi-automatic quantification. IEEE Trans Bio- med Eng 2002;49:912-7.
  • Swanson C, Cocker KD, Parker KH, et al. Semiautomated computer analysis of vessel growth in preterm infants without and with ROP. Br J Ophthalmol 2003;87:1474-7.
  • Grisan E, Pesce A, Giani A, Foracchia M, Ruggeri A. A new tracking system for the robust extraction of retinal vessel structure. ConfProc IEEE Eng Med Biol Soc 2004;3:1620-3.
  • Wallace DK, Kylstra JA, Chesnutt DA. Prognostic significance of vas- cular dilation and tortuosity insufficient for plus disease in retinopathy of prematurity. J AAPOS 2000;4:224.9
  • Maldonado RS, Yuan E, Tran-Viet D, et al. Three-dimensional assess- ment of vascular and perivascular characteristics in subjects with reti- nopathy of prematurity. Ophthalmology 2014;121:1289-96.
  • Freedman SF, Kylstra JA, Capowski JJ, et al. Observer sensitivity to retinal vessel diameter and tortuosity in retinopathy of prematurity: A model system. J Pediatr Ophthalmol Strabismus.1996;33:248-54.
  • Rao R, Jonsson NJ, Ventura C, et al Plusdisease in retinopathy of pre- maturity: diagnostic impact of field of viewRetina 2012 ;32:1148-55.
  • Jandeck C. New therapeutic approaches in thetreatment of retino- pathy of prematurity. KlinMonblAugenheilkd 2009;226:914-20.
APA YUMUŞAK M, MUTLU F, SARICA Ü, Oğurel R (2015). Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon. , 179 - 185.
Chicago YUMUŞAK MEHMET ERHAN,MUTLU Fatih Mehmet,SARICA Ümit,Oğurel Reyhan Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon. (2015): 179 - 185.
MLA YUMUŞAK MEHMET ERHAN,MUTLU Fatih Mehmet,SARICA Ümit,Oğurel Reyhan Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon. , 2015, ss.179 - 185.
AMA YUMUŞAK M,MUTLU F,SARICA Ü,Oğurel R Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon. . 2015; 179 - 185.
Vancouver YUMUŞAK M,MUTLU F,SARICA Ü,Oğurel R Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon. . 2015; 179 - 185.
IEEE YUMUŞAK M,MUTLU F,SARICA Ü,Oğurel R "Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon." , ss.179 - 185, 2015.
ISNAD YUMUŞAK, MEHMET ERHAN vd. "Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon". (2015), 179-185.
APA YUMUŞAK M, MUTLU F, SARICA Ü, Oğurel R (2015). Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon. Retina-Vitreus, 23(2), 179 - 185.
Chicago YUMUŞAK MEHMET ERHAN,MUTLU Fatih Mehmet,SARICA Ümit,Oğurel Reyhan Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon. Retina-Vitreus 23, no.2 (2015): 179 - 185.
MLA YUMUŞAK MEHMET ERHAN,MUTLU Fatih Mehmet,SARICA Ümit,Oğurel Reyhan Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon. Retina-Vitreus, vol.23, no.2, 2015, ss.179 - 185.
AMA YUMUŞAK M,MUTLU F,SARICA Ü,Oğurel R Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon. Retina-Vitreus. 2015; 23(2): 179 - 185.
Vancouver YUMUŞAK M,MUTLU F,SARICA Ü,Oğurel R Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon. Retina-Vitreus. 2015; 23(2): 179 - 185.
IEEE YUMUŞAK M,MUTLU F,SARICA Ü,Oğurel R "Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon." Retina-Vitreus, 23, ss.179 - 185, 2015.
ISNAD YUMUŞAK, MEHMET ERHAN vd. "Prematüre Retinopatisi, Tanısı ve Değerlendirmede Standardizasyon". Retina-Vitreus 23/2 (2015), 179-185.
Sayfa Oluşturulma Tarihi
22-04-2024 23:7

İLETİŞİM

TÜBİTAK ULAKBİM TR Dizin

Yüzüncüyıl, İşçi Blokları Mahallesi

Muhsin Yazıcıoğlu Caddesi No:51/C

06530 Çankaya / ANKARA +90 (312) 298 92 00

trdizin@tubitak.gov.tr

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © Tüm Hakları Saklıdır. Gizlilik Politikası Kullanım Şartları